ETF Managers Group’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $14.5K | Buy |
+9,819
| New | +$14.5K | ﹤0.01% | 681 |
|
|
2022
Q4 | – | Sell |
-9,969
| Closed | -$32K | – | 553 |
|
|
2022
Q3 | $32K | Sell |
9,969
-769
| -7% | -$2.47K | ﹤0.01% | 681 |
|
|
2022
Q2 | $58K | Buy |
10,738
+1,893
| +21% | +$10.2K | ﹤0.01% | 701 |
|
|
2022
Q1 | $56K | Buy |
8,845
+111
| +1% | +$703 | ﹤0.01% | 653 |
|
|
2021
Q4 | $79K | Sell |
8,734
-1,445
| -14% | -$13.1K | ﹤0.01% | 649 |
|
|
2021
Q3 | $99K | Buy |
10,179
+1,723
| +20% | +$16.8K | ﹤0.01% | 641 |
|
|
2021
Q2 | $75K | Sell |
8,456
-203
| -2% | -$1.8K | ﹤0.01% | 630 |
|
|
2021
Q1 | $74K | Sell |
8,659
-5,091
| -37% | -$43.5K | ﹤0.01% | 647 |
|
|
2020
Q4 | $134K | Sell |
13,750
-1,981
| -13% | -$19.3K | ﹤0.01% | 590 |
|
|
2020
Q3 | $219K | Buy |
15,731
+7,586
| +93% | +$106K | 0.01% | 570 |
|
|
2020
Q2 | $142K | Buy |
+8,145
| New | +$142K | 0.01% | 569 |
|